Cargando…
Therapeutic potential of targeting MYCN: A case series report of neuroblastoma with MYCN amplification
INTRODUCTION: Neuroblastoma (NB) with MYCN amplification has a poor prognosis and high mortality. The potential molecular biological relationship between clinical features and MYCN amplification should be explored. METHODS: NB patients were examined by fluorescence in situ hybridization (FISH) for M...
Autores principales: | Huang, Can, Jiang, Shayi, Yang, Jingwei, Liao, Xuelian, Li, Yanhua, Li, Shanshan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7310875/ https://www.ncbi.nlm.nih.gov/pubmed/32569234 http://dx.doi.org/10.1097/MD.0000000000020853 |
Ejemplares similares
-
Bone and bone marrow involvement in neuroblastoma: A case report
por: Huang, Can, et al.
Publicado: (2020) -
MYCN Amplifications and Metabolic Rewiring in Neuroblastoma
por: Pouliou, Marialena, et al.
Publicado: (2023) -
Implementation of the plasma MYCN/NAGK ratio to detect MYCN amplification in patients with neuroblastoma
por: Su, Yan, et al.
Publicado: (2020) -
MYCN amplification and ATRX mutations are incompatible in neuroblastoma
por: Zeineldin, Maged, et al.
Publicado: (2020) -
MYCN is amplified during S phase, and c-myb is involved in controlling MYCN expression and amplification in MYCN-amplified neuroblastoma cell lines
por: Aygun, Nevim, et al.
Publicado: (2019)